1 online
 
Change language:    
Menu

Searching in abstracts

Sponzor



Programme May 13, 2007

    HRADEC KRÁLOVÉ (exhibition hall E 1st floor, former Business Center I)  -  Sunday 13/05/2007  

 11:50  Opening Ceremony of the 15th Alpe-Adria Cardiology Meeting M. Aschermann, R. Čerbák (Praha, Brno)
 12:00 - 12:45  Cardiosurgery Chairpersons: P. Fioretti, R. Čerbák (Udine, Italy, Brno)
 12:001. PRESENT AND FUTURE TRENDS OF ADVANCED NON INVASIVE CARDIAC IMAGING P. Fioretti (Udine, Italy) (UID: 79)
 12:152. AORTIC SURGERY IN NA HOMOLCE HOSPITAL – BIG PROGRAM FOR SMALL DEPARTMENT J. Benedík, Š. Černý, P. Pavel, M. Michel, P. Šebesta, M. Benešová, P. Jehlička, D. Doubek, T. Mach (Praha) (UID: 19)
 12:253. PEDOF PROBE MEASUREMENT OF PEAK VELOCITY AVOIDS MISCLASSIFICATION OF AORTIC STENOSIS SEVERITY IN TWENTY-FIVE PERCENT OF PATIENTS WITH AORTIC STENOSIS R. Marinigh, L. Badano, M. Cinello, D. Pavoni, N. Pezzutto, P. Gianfagna, P. Fioretti (Udine, Italy, Udine) (UID: 70)
 12:354. ACCURACY OF REAL-TIME 3D ECHOCARDIOGRAPHY IN ASSESSING THE ANATOMY OF THE MITRAL VALVE IN PATIENTS UNDERGOING SURGERY FOR SEVERE DEGENERATIVE MITRAL REGURGITATION M. Cinello, L. Badano, N. Pezzutto, D. Pavoni, R. Marinigh, P. Gianfagna, P. Fioretti (Udine, Italy) (UID: 71)
 12:45  Lunch  
 13:00 - 14:30  Heart failure and Heart transplantation Chairpersons: D. Petrač, J. Špinar (Zagreb, Croatia (Hrvatska), Brno)
 13:005. RISK STRATIFICATION IN NONISCHEMIC CARDIOMYOPATHY D. Petrač (Zagreb, Croatia (Hrvatska)) (UID: 94)
 13:156. N-TERMINAL PRO BRAIN NATRIURETIC PEPTIDE PREDICTS EXERCISE TOLERANCE IN HEART TRANSPLANT RECIPIENTS B. Stanek, A. Aliabadi, S. Rödler, M. Grimm (Wien, Austria) (UID: 92)
 13:257. METABOLIC LIVER FUNCTION IN PATIENTS WITH HEART FAILURE AND ARTERIAL HYPERTENSION M. Hendrichová, F. Málek, K. Krátká, M. Sedláková, J. Vránová, J. Horák (Praha) (UID: 5)
 13:358. EFFICACY AND SAFETY OF COMBINED THERAPY WITH ATORVASTATIN AND TACROLIMUS IN HEART TRANSPLANT RECIPIENTS B. Skalická, I. Málek (Praha) (UID: 33)
 13:459. WHAT CAN MEAN IF WE SAY "PALLIATIVE CARE ON PATIENTS WITH ADVANCED HEART FAILURE"? L. Kabelka, J. Vítovec (Rajhrad, Brno) (UID: 38)
 13:5510. OUR EXPERIENCE WITH THE USE OF IMPEDANCE CARDIOGRAPHY TO MONITOR HAEMODYNAMICS IN PATIENTS WITH ACUTE HEART FAILURE – COMPARISON WITH TERMODILUTION R. Miklík, J. Pařenica, M. Poloczek, O. Toman, J. Špinar (Brno) (UID: 60)
 14:0511. IMPACT OF SPECIALIZED HEART FAILURE OUTPATIENT UNITS ON THE PREVALENCE OF HOSPITALISATIONS DUE TO CONGESTIVE HEART FAILURE IN DIFFERENT REGIONS OF AUSTRIA I. Kozanli, D. Cilesiz, R. Jarai, G. Jakl, K. Huber (Vienna, Austria) (UID: 61)
 14:30 - 15:30  Cardiovascular risk Chairpersons: M. Kenda, J. Hradec (Ljubljana, Slovenia, Praha)
 14:3012. CARDIOVASCULAR DISEASE IN ELDERLY - A BURNING PROBLEM M. Kenda (Ljubljana, Slovenia) (UID: 81)
 14:4513. DIFFERENT WAYS OF SMOKING BUT THE SAME HAZARD TO CARDIOVASCULAR SYSTEM: SHISHA SMOKING COMPARED WITH CIGARETTE SMOKING REGARDING THEIR EFFECT ON BLOOD PRESSURE AND ITS REGULATION M. Al-Kubati, A. Al-Kubati, B. Fišer, S. Janoušek (Brno, Taiz, Yemen, Yemen) (UID: 32)
 14:5514. PREDICTIVE FACTORS FOR MACRO- AND MICROANGIOPATHY IN DIABETES MELLITUS TYPE 2. B. Nussbaumerová, H. Rosolová, J. Ferda, J. Šimon, I. Šípová, P. Šifalda (Plzeň) (UID: 45)
 15:0515. SHORT TERM CONTROL OF BLOOD PRESSURE: COHERENCE BETWEEN BLOOD PRESSURE AND SYSTEMIC PERIPHERAL RESISTANCE FLUCTUATIONS AROUND 0.1 HZ J. Siegelová, B. Fišer, J. Dušek, H. Svačinová, P. Vank, P. Dobšák, P. Homolka (Brno) (UID: 20)
 15:1516. EVALUATION OF CAROTID - FEMORAL ARTERIAL PULSE VELOCITY AND ITS RELATIONSHIP TO NATRIURETIC PEPTIDES LEVELS IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME OR TYPE 2 DIABETES MELLITUS J. Hanuš, J. Špác, M. Souček (Brno) (UID: 17)
 15:30  The End of the Alpe-Adria Scientific Program  
 15:31  Break  
 15:45 - 16:45  Symposium Abbott Laboratories, s.r.o.Intervence inhibitory ACE - příběh, který nekončí... Chairpersons: J. Widimský jr. (Praha)
 15:45  KARDIOMETABOLICKÉ RIZIKO A NOVÁ STRATEGIE PREVENCE KV NEMOCÍ A DIABETU V 21. STOLETÍ H. Rosolová (Plzeň)
 16:05  INHIBITORY ACE V LÉČBĚ PACIENTŮ S VYSOKÝM KARDIOVASKULÁRNÍM RIZIKEM J. Widimský jr. (Praha)
 16:25  ANTIARYTMICKÉ ÚČINKY INHIBITORU ACE - NOVÝ PŘÍSTUP V PREVENCI ARYTMIÍ? R. Hatala (Bratislava, SR)
 16:45  End of program